SRR1479912
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- KRAS_SIGNALING_DN+0.149
- SPERMATOGENESIS+0.091
- TNFA_SIGNALING_VIA_NFKB-0.036
- G2M_CHECKPOINT-0.055
- APICAL_SURFACE-0.058
- MITOTIC_SPINDLE-0.061
- PANCREAS_BETA_CELLS-0.072
- E2F_TARGETS-0.074
- IL6_JAK_STAT3_SIGNALING-0.079
- WNT_BETA_CATENIN_SIGNALING-0.083
Top 10 suppressed
- OXIDATIVE_PHOSPHORYLATION-0.544
- NOTCH_SIGNALING-0.503
- ADIPOGENESIS-0.453
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.422
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.420
- TGF_BETA_SIGNALING-0.403
- HEDGEHOG_SIGNALING-0.378
- FATTY_ACID_METABOLISM-0.374
- CHOLESTEROL_HOMEOSTASIS-0.351
- UV_RESPONSE_DN-0.338
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1446071 | GTEX | — | 0.966 |
| 2 | SRR1485789 | GTEX | — | 0.952 |
| 3 | SRR1471374 | GTEX | — | 0.950 |
| 4 | SRR1452056 | GTEX | — | 0.933 |
| 5 | SRR1466357 | GTEX | — | 0.931 |
| 6 | SRR627453 | GTEX | — | 0.930 |
| 7 | SRR598533 | GTEX | — | 0.927 |
| 8 | SRR1455060 | GTEX | — | 0.925 |
| 9 | SRR627299 | GTEX | — | 0.923 |
| 10 | SRR1315799 | GTEX | — | 0.922 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 2 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.149 | Remibrutinib | — uncovered |
| SPERMATOGENESIS | 0.091 | Inavolisib | — uncovered |